-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on Replimune Group, Raises Price Target to $31

Benzinga·10/29/2026 19:02:21
Listen to the news
Leerink Partners analyst Daina Graybosch maintains Replimune Group (NASDAQ:REPL) with a Outperform and raises the price target from $19 to $31.